CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.97 +0.22 (+4.63%)
As of: Oct 23, 2026 · 3:46 PM EDT

CNS Pharmaceuticals (CNSP) Amortization of Deferred Charges (2018 - 2025)

Updated

CNS Pharmaceuticals' Amortization of Deferred Charges was $334,138 in FY2022.

Analysis

CNS Pharmaceuticals (CNSP) Amortization of Deferred Charges (2018 - 2025) Analysis & Trends

  • Amortization of Deferred Charges shows a three-year compound annual growth rate of 48.4% (FY2019 to FY2022).
  • The FY2022 figure marks the lowest annual Amortization of Deferred Charges since FY2019.
  • Per Business Quant data, Amortization of Deferred Charges in earlier years was $102,225 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 CNS Pharmaceuticals 2.20 Mn -40.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 14,637.00
Dec 31, 2019 84,143.00
Jun 30, 2019 9,165.00
Mar 31, 2019 8,917.00
Dec 31, 2018 3,337.00
Sep 30, 2018 12,667.00
API Access

CNS Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CNSP&period=max&api_key=YOUR_API_KEY